JP2015506347A5 - - Google Patents

Download PDF

Info

Publication number
JP2015506347A5
JP2015506347A5 JP2014548899A JP2014548899A JP2015506347A5 JP 2015506347 A5 JP2015506347 A5 JP 2015506347A5 JP 2014548899 A JP2014548899 A JP 2014548899A JP 2014548899 A JP2014548899 A JP 2014548899A JP 2015506347 A5 JP2015506347 A5 JP 2015506347A5
Authority
JP
Japan
Prior art keywords
optionally substituted
nitrogen
membered
oxygen
sulfur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014548899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015506347A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/070980 external-priority patent/WO2013096637A1/en
Publication of JP2015506347A publication Critical patent/JP2015506347A/ja
Publication of JP2015506347A5 publication Critical patent/JP2015506347A5/ja
Pending legal-status Critical Current

Links

JP2014548899A 2011-12-23 2012-12-20 ヘテロアリールおよびその使用 Pending JP2015506347A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161579711P 2011-12-23 2011-12-23
US61/579,711 2011-12-23
US201261672030P 2012-07-16 2012-07-16
US61/672,030 2012-07-16
US201261716172P 2012-10-19 2012-10-19
US61/716,172 2012-10-19
PCT/US2012/070980 WO2013096637A1 (en) 2011-12-23 2012-12-20 Heteroaryls and uses thereof

Publications (2)

Publication Number Publication Date
JP2015506347A JP2015506347A (ja) 2015-03-02
JP2015506347A5 true JP2015506347A5 (enExample) 2016-02-18

Family

ID=48655164

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014548902A Pending JP2015503505A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用
JP2014548899A Pending JP2015506347A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用
JP2014548896A Pending JP2015503504A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014548902A Pending JP2015503505A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014548896A Pending JP2015503504A (ja) 2011-12-23 2012-12-20 ヘテロアリールおよびその使用

Country Status (7)

Country Link
US (3) US20130165472A1 (enExample)
EP (3) EP2793894A4 (enExample)
JP (3) JP2015503505A (enExample)
AR (3) AR089447A1 (enExample)
TW (3) TW201332989A (enExample)
UY (3) UY34538A (enExample)
WO (3) WO2013096630A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9029411B2 (en) 2008-01-25 2015-05-12 Millennium Pharmaceuticals, Inc. Thiophenes and uses thereof
JP2012516329A (ja) 2009-01-30 2012-07-19 ミレニアム ファーマシューティカルズ, インコーポレイテッド Pi3k阻害剤としてのヘテロアリールおよびその使用
US9090601B2 (en) 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
EP2603216A4 (en) 2010-08-11 2013-12-18 Millennium Pharm Inc HETEROARYLE AND USES THEREOF
WO2012021696A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
CA2814688A1 (en) 2010-10-13 2012-04-19 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
JP2017506618A (ja) 2013-08-28 2017-03-09 メディベイション テクノロジーズ, インコーポレイテッド 複素環式化合物および使用方法
US9802960B2 (en) 2014-01-14 2017-10-31 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
US10202373B2 (en) 2014-01-14 2019-02-12 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2016050921A1 (en) * 2014-10-02 2016-04-07 F. Hoffmann-La Roche Ag Pyrazole carboxamide compounds for use in the treament of disorders mediated by bruton's tyrosine kinase (btk)
CA2977539A1 (en) 2015-03-04 2016-09-09 Medivation Technologies, Inc. Sterol regulatory element-binding proteins (srebps) inhibitors
US10183015B2 (en) 2015-03-04 2019-01-22 Medivation Technologies Llc Heterocyclic compounds and methods of use
BR112018068681A2 (pt) 2016-03-16 2019-01-15 Bayer Cropscience Ag derivados de n-(cianobenzil)-6-(ciclopropil-carbonilamino)-4-(fenil)-piridina-2-carboxamida e compostos relacionados como pesticidas e agentes de proteção de plantas
EP3284739A1 (de) 2017-07-19 2018-02-21 Bayer CropScience Aktiengesellschaft Substituierte (het)arylverbindungen als schädlingsbekämpfungsmittel
MA49705A (fr) 2017-07-28 2021-03-31 Yuhan Corp Intermédiaires utiles pour la synthèse d'un inhibiteur sélectif vis-à-vis de la protéine kinase et leurs procédés de préparation
MX2022008743A (es) 2017-07-28 2023-02-02 Yuhan Corp Proceso mejorado para preparar derivados de aminopirimidina.
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
CN110041252A (zh) * 2019-05-22 2019-07-23 南京合巨药业有限公司 一种2-氯-4-肼基吡啶的制备方法
EP3976605B1 (en) * 2019-05-31 2025-08-20 Bantam Pharmaceutical, LLC Methods for making thiazolylpyrazole carboxylic acids and intermediates therefor
WO2021011723A1 (en) * 2019-07-18 2021-01-21 Avidence Therapeutics, Inc. Anti-osteoarthritis hydantoin compounds and related compositions and methods
WO2025117722A1 (en) * 2023-11-27 2025-06-05 Rubedo Life Sciences, Inc. Carbon linked bcl inhibitors and senolytic compounds and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
MX9300141A (es) * 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
GB2306108A (en) * 1995-10-13 1997-04-30 Merck & Co Inc Treatment of Raf-mediated cancers with imidazole derivatives
CA2315647C (en) * 1997-12-22 2009-09-29 Bayer Corporation Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas
WO2002092573A2 (en) * 2001-05-16 2002-11-21 Vertex Pharmaceuticals Incorporated Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
DE60216115T2 (de) * 2001-08-01 2007-05-31 Merck & Co., Inc. BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
US7582631B2 (en) * 2004-01-14 2009-09-01 Amgen Inc. Substituted heterocyclic compounds and methods of use
AU2005319455A1 (en) * 2004-12-21 2006-06-29 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors
US20090036435A1 (en) * 2005-01-21 2009-02-05 Astex Therapeutics Limited Pharmaceutical Compounds
EP2044061A2 (en) * 2006-07-20 2009-04-08 Mehmet Kahraman Benzothiophene inhibitors of rho kinase
UY30892A1 (es) * 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
EP2134175A4 (en) * 2007-03-29 2012-01-11 Glaxosmithkline Llc HAMMER OF ACT ACTIVITY
GB0709031D0 (en) * 2007-05-10 2007-06-20 Sareum Ltd Pharmaceutical compounds
JP5561702B2 (ja) * 2007-08-02 2014-07-30 アムジエン・インコーポレーテツド Pi3キナーゼ調節剤および使用方法
EA201001456A1 (ru) * 2008-03-21 2011-06-30 Новартис Аг Новые гетероциклические соединения и их применение
ES2491522T3 (es) * 2008-06-19 2014-09-08 Millennium Pharmaceuticals, Inc. Derivados de tiofeno o tiazol y su uso como inhibidores de PI3K
WO2009156484A2 (en) * 2008-06-27 2009-12-30 Novartis Ag Organic compounds
JP2012516329A (ja) * 2009-01-30 2012-07-19 ミレニアム ファーマシューティカルズ, インコーポレイテッド Pi3k阻害剤としてのヘテロアリールおよびその使用
WO2010127152A2 (en) * 2009-04-29 2010-11-04 Irm Llc Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors
CA2760778A1 (en) * 2009-05-13 2010-11-18 Amgen Inc. Heteroaryl compounds as pikk inhibitors
JO3002B1 (ar) * 2009-08-28 2016-09-05 Irm Llc مركبات و تركيبات كمثبطات كيناز بروتين
US8623857B2 (en) * 2010-05-26 2014-01-07 Merck Sharp & Dohme Corp. N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
WO2012084678A1 (en) * 2010-12-23 2012-06-28 Syngenta Participations Ag Novel imidazoles useful as plant fungicides
MX340013B (es) * 2011-03-21 2016-06-22 Hoffmann La Roche Compuestos de benzoxazepina selectivos para fosfatidilinositol 3-cinasa (pi3k) p110 delta y metodos de uso.
IN2014CN04676A (enExample) * 2011-12-21 2015-09-18 Ono Pharmaceutical Co

Similar Documents

Publication Publication Date Title
JP2015506347A5 (enExample)
JP2015503505A5 (enExample)
JP2015503504A5 (enExample)
JP2011510080A5 (enExample)
TWI287004B (en) A pyridone derivative having an affinity effect for cannabinoid 2 type receptor
CA2563895C (en) Disalt inhibitors of il-12 production
TWI457337B (zh) 呋呫基苯并咪唑
JP2008513508A5 (enExample)
JP2013533318A5 (enExample)
JP2014512406A5 (enExample)
JP2016505063A (ja) ソルチリン阻害剤としてのn置換された5置換フタルアミド酸
ES2824801T3 (es) Sal de compuesto heterocíclico sustituido con halógeno
KR20060123208A (ko) 피라진 유도체 및 이의 약학적 용도
JP2020532550A (ja) リゾホスファチジン酸受容体1(lpar1)阻害剤化合物
JP6666458B2 (ja) 置換のアミノ6員窒素含有複素環式化合物およびその製造と使用
AU2006267454A2 (en) Benzoimidazole compound capable of inhibiting prostaglandin D synthetase
JP2016508152A (ja) Cracチャネル阻害薬としての、ピラゾリルをベースとするカルボキサミド類i
CN106243047B (zh) 具有VEGFR-2和B-raf双重抑制作用的喹喔啉酮双芳基脲及其衍生物、制备方法及其应用
US20100152240A1 (en) Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
CN104334528A (zh) (2-杂芳基氨基)琥珀酸衍生物
KR20150103752A (ko) Crac 채널 억제제로서의 피라졸릴계 카복스아미드 ⅱ
JP2016513726A (ja) がん細胞成長阻害剤としてのテトラヒドロイソキノリン−2−イル−(キナゾリン−4−イル)メタノン化合物
JP2008088107A (ja) 新規ピリダジン誘導体
WO2017198179A1 (zh) 新型噻唑类衍生物在治疗炎性肠病中的应用
JP6464244B2 (ja) Tert−ブチル n−[2−{4−[6−アミノ−5−(2,4−ジフルオロベンゾイル)−2−オキソピリジン−1(2h)−イル]−3,5−ジフルオロフェニル}エチル)−l−アラニネート又はその製薬上許容され得る塩、水和物もしくは溶媒和物